and OWNERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY RECEIPTS Deposit Agreement Dated as of October 26, 2000Deposit Agreement • November 13th, 2007 • Crucell Nv • Services-commercial physical & biological research • New York
SHAREHOLDER AGREEMENT SEPTEMBER 28, 2009Shareholder Agreement • April 7th, 2010 • Crucell Nv • Services-commercial physical & biological research
EMPLOYMENT AGREEMENT BETWEEN AND DATED JUNE 30, 2006Employment Agreement • June 13th, 2007 • Crucell Nv • Services-commercial physical & biological research
The General Meeting of Shareholders of Crucell on June 3, 2004 resolved to appoint the Executive as member of the Management Board as per January 26, 2004;
REGISTRATION RIGHTS AGREEMENT dated as of September 28, 2009 between CRUCELL N.V. and JHC NEDERLAND B.V.Registration Rights Agreement • June 25th, 2010 • Crucell Nv • Services-commercial physical & biological research • New York
REGISTRATION RIGHTS AGREEMENT, dated as of September 28, 2009 (this “Agreement”), between Crucell N.V., a public limited liability company incorporated under the laws of the Netherlands (the “Company”), and JHC Nederland B.V., a private company with limited liability incorporated under the laws of the Netherlands (“Investor”).
Crucell N.V. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Portions denoted by ***Equity Purchase Agreement • April 7th, 2010 • Crucell Nv • Services-commercial physical & biological research
COLLABORATION AGREEMENTCollaboration Agreement • June 30th, 2006 • Crucell Nv • Services-commercial physical & biological research
This Collaboration Agreement is made and entered into as of April 30, 2001 by and among Chiron Behring GmbH & Co, a company incorporated in Germany, with offices at Emil von Behring Strasse 76, 35041 Marburg, Germany (“Chiron Behring”), Chiron S.p.A., a company incorporated in Italy, with offices at Via Fiorentina 1, 53100 Siena, Italy (“Chiron S.p.A.”, and together with Chiron Behring GmbH & Co, “Chiron”), Rhein Biotech N.V., a company incorporated in the Netherlands, with offices at Gaetano Martinolaan 95, 6229 GS Maastricht, The Netherlands (“Rhein Biotech”), and GreenCross Vaccine Corporation, a company incorporated in the Republic of Korea, with offices at 303 Bojung-Ri, Koosung-Eup, Yongin 449-770, Republic of Korea (“GCVC”, and together with Rhein Biotech, “Rhein Biotech and GCVC”).
EMPLOYMENT AGREEMENT BETWEEN AND DATED JUNE 30, 2006Employment Agreement • June 13th, 2007 • Crucell Nv • Services-commercial physical & biological research
The General Meeting of Shareholders of Crucell on June 3, 2004 resolved to appoint the Executive as member of the Management Board as per January 26, 2004;
Crucell N.V.Crucell Nv • December 7th, 2007 • Services-commercial physical & biological research
We refer to the Supply Agreement dated 12 November 2001 (the Agreement) between CSL Limited (CSL) and Berna Biotech Ltd (Berna) for the supply of Product on a worldwide non-exclusive basis subject to specified Exclusive and Excluded Territories.
EMPLOYMENT AGREEMENTCrucell Nv • April 14th, 2005 • Services-commercial physical & biological research
Crucell is a leading biotechnology company, principally engaged in the discovery and development of biopharmaceutical products that utilize the immune system to combat diseases.
COLLABORATION AGREEMENTCollaboration Agreement • December 7th, 2007 • Crucell Nv • Services-commercial physical & biological research • California
This Collaboration Agreement is made and entered into as of April 30, 2001 by and among Chiron Behring GmbH & Co, a company incorporated in Germany, with offices at Emil von Behring Strasse 76, 35041 Marburg, Germany (“Chiron Behring”), Chiron S.p.A., a company incorporated in Italy, with offices at Via Fiorentina 1, 53100 Siena, Italy (“Chiron S.p.A.”, and together with Chiron Behring GmbH & Co, “Chiron”), Rhein Biotech N.V., a company incorporated in the Netherlands, with offices at Gaetano Martinolaan 95, 6229 GS Maastricht, The Netherlands (“Rhein Biotech”), and GreenCross Vaccine Corporation, a company incorporated in the Republic of Korea, with offices at 303 Bojung-Ri, Koosung-Eup, Yongin 449-770, Republic of Korea (“GCVC”, and together with Rhein Biotech, “Rhein Biotech and GCVC”).
EMPLOYMENT CONTRACTCrucell Nv • April 18th, 2003 • Services-commercial physical & biological research
Transaction AgreementTransaction Agreement • July 6th, 2006 • Crucell Nv • Services-commercial physical & biological research
EMPLOYMENT AGREEMENT BETWEEN AND EFFECTIVE AS PER SEPTEMBER 1, 2007Employment Agreement • April 22nd, 2009 • Crucell Nv • Services-commercial physical & biological research
Crucell is a leading biotechnology company developing vaccine and antibody products to prevent and treat infectious diseases;
Berna Biotech Ltd Rehhagstrasse 79 CH-3018 Bern SWITZERLAND Attention: Kuno Sommer, Chief Executive Officer Dear Kuno, Letter of Amendment to Supply AgreementSupply Agreement • July 6th, 2006 • Crucell Nv • Services-commercial physical & biological research
We refer to the Supply Agreement dated 12 November 2001 (the Agreement) between CSL Limited (CSL) and Berna Biotech Ltd (Berna) for the supply of Product on a worldwide non-exclusive basis subject to specified Exclusive and Excluded Territories.
PER.CX COLLABORATION and LICENSE AGREEMENT CRUCELL HOLLAND B.V.—AVENTIS PASTEUR S.ACollaboration and License Agreement • February 27th, 2004 • Crucell Nv • Services-commercial physical & biological research
CRUCELL HOLLAND B.V., a Dutch company with offices located at Archimedesweg 4, 2301 CN Leiden, the Netherlands, (hereinafter "CRUCELL");
EMPLOYMENT AGREEMENT (translation from Dutch)Crucell Nv • April 14th, 2005 • Services-commercial physical & biological research
Mr. Brus is available to dedicate himself on a national and international level for Introgene and is not affiliated to any other third party in that respect;
Collaboration AgreementCollaboration Agreement • April 18th, 2003 • Crucell Nv • Services-commercial physical & biological research
COLLABORATION AGREEMENT dated this 18th day of December, 2002 by and between CRUCELL N.V. and CRUCELL HOLLAND B.V., both Netherlands corporations having offices at Archimedesweg 4, 2333 CN, Leiden, The Netherlands (jointly and severally "Crucell") and DSM BIOLOGICS HOLDING, INC. and DSM BIOLOGICS COMPANY, INC., Quebec corporations having offices at 6000 Royalmount Avenue, Montreal, Canada and DSM BIOLOGICS COMPANY, B.V., a Netherlands corporation having offices at Zuiderweg 72/2, Groningen, The Netherlands (jointly and severally "DSM").
Turn Key Contract betweenCrucell Nv • July 6th, 2006 • Services-commercial physical & biological research
Notice 11.3. The Seller shall in writing inform the Purchaser fourteen (14) calendar days prior to the expected date of Mechanical Completion.
THE BANK OF NEW YORKDeposit Agreement • November 13th, 2007 • Crucell Nv • Services-commercial physical & biological research
Deposit Agreement (the “Deposit Agreement”), dated as of October 26, 2000, among Crucell N.V., The Bank of New York, as Depositary, and the Owners and Beneficial Owners of American Depositary Receipts
